Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer

See Locations Near You

Summary

This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of sunitinib combined with docetaxel versus docetaxel, administered as first-line treatment, in patients with unresectable locally recurrent or metastatic breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Breast cancer with evidence of unresectable locally recurrent, or metastatic disease
Her-2 negative tumors

Exclusion Criteria:

Patients for whom docetaxel is contraindicated
Clinical presentation of inflammatory carcinoma with no other measurable disease

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

594

Study ID:

NCT00393939

Recruitment Status:

Completed

Sponsor:

Pfizer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 137 Locations for this study

See Locations Near You

Pfizer Investigational Site
Berkely California, 94704, United States
Pfizer Investigational Site
Shreveport Louisiana, 71103, United States
Pfizer Investigational Site
Beaumont Texas, 77701, United States
Pfizer Investigational Site
Burleson Texas, 76028, United States
Pfizer Investigational Site
Cleburne Texas, 76031, United States
Pfizer Investigational Site
Fort Worth Texas, 76104, United States
Pfizer Investigational Site
Mineral Wells Texas, 76067, United States
Pfizer Investigational Site
Weatherford Texas, 76086, United States
Pfizer Investigational Site
La Plata Buenos Aires, B1902, Argentina
Pfizer Investigational Site
Pergamino Buenos Aires, B2700, Argentina
Pfizer Investigational Site
Burnos Aires , C1426, Argentina
Pfizer Investigational Site
Tweed Heads New South Wales, 2485, Australia
Pfizer Investigational Site
Redcliffe Queensland, 4020, Australia
Pfizer Investigational Site
Adelaide South Australia, 5000, Australia
Pfizer Investigational Site
Brighton Victoria, 3186, Australia
Pfizer Investigational Site
Malvern Victoria, 3144, Australia
Pfizer Investigational Site
Ringwood East Victoria, 3135, Australia
Pfizer Investigational Site
Perth Western Australia, 6000, Australia
Pfizer Investigational Site
Salzburg , A-502, Austria
Pfizer Investigational Site
Wien , A-109, Austria
Pfizer Investigational Site
Wien , A-110, Austria
Pfizer Investigational Site
Wien , A-116, Austria
Pfizer Investigational Site
Brasschaat , 2930, Belgium
Pfizer Investigational Site
Bruxelles , 1000, Belgium
Pfizer Investigational Site
Verviers , 4800, Belgium
Pfizer Investigational Site
Surrey British Columbia, V3V 1, Canada
Pfizer Investigational Site
Hamilton Ontario, L8V 5, Canada
Pfizer Investigational Site
Kingston Ontario, K7L 2, Canada
Pfizer Investigational Site
Kingston Ontario, K7L 5, Canada
Pfizer Investigational Site
Sudbury Ontario, P3E 5, Canada
Pfizer Investigational Site
Bogota Cundinamarca, , Colombia
Pfizer Investigational Site
Pereira Risaralda, 0, Colombia
Pfizer Investigational Site
Cali Valle del Cauca, 0, Colombia
Pfizer Investigational Site
Brno , 656 5, Czech Republic
Pfizer Investigational Site
Novy Jicin , 741 0, Czech Republic
Pfizer Investigational Site
Praha 5 , 150 0, Czech Republic
Pfizer Investigational Site
Praha 8 , 180 0, Czech Republic
Pfizer Investigational Site
Tampere , 33520, Finland
Pfizer Investigational Site
Turku , 20520, Finland
Pfizer Investigational Site
Bordeaux CEDEX , 33000, France
Pfizer Investigational Site
Dijon , 21079, France
Pfizer Investigational Site
NANTES Cedex 2 , 44202, France
Pfizer Investigational Site
Reims , 51100, France
Pfizer Investigational Site
Saint Cloud , 92210, France
Pfizer Investigational Site
Saint-Priest-en-Jarez Cedex , 42270, France
Pfizer Investigational Site
Strasbourg , 67000, France
Pfizer Investigational Site
Tours , 37000, France
Pfizer Investigational Site
Villejuif , 94805, France
Pfizer Investigational Site
Berlin , 12200, Germany
Pfizer Investigational Site
Chemnitz , 09116, Germany
Pfizer Investigational Site
Essen , 45122, Germany
Pfizer Investigational Site
Hildesheim , 31134, Germany
Pfizer Investigational Site
Karlsruhe , 76135, Germany
Pfizer Investigational Site
Leverkusen , 51375, Germany
Pfizer Investigational Site
Magdeburg , 39108, Germany
Pfizer Investigational Site
Marburg , 35043, Germany
Pfizer Investigational Site
Oldenburg , 26133, Germany
Pfizer Investigational Site
Ravensburg , 88212, Germany
Pfizer Investigational Site
Rosenheim , 83022, Germany
Pfizer Investigational Site
Wuerzburg , 97080, Germany
Pfizer Investigational Site
Budapest , 1122, Hungary
Pfizer Investigational Site
Budapest , 1145, Hungary
Pfizer Investigational Site
Kaposvar , 7400, Hungary
Pfizer Investigational Site
Szentes , 6600, Hungary
Pfizer Investigational Site
Dublin , 4, Ireland
Pfizer Investigational Site
Dublin , 7, Ireland
Pfizer Investigational Site
Dublin , 8, Ireland
Pfizer Investigational Site
Galway , , Ireland
Pfizer Investigational Site
Catania , 95126, Italy
Pfizer Investigational Site
Cattolica (RN) , 47841, Italy
Pfizer Investigational Site
Cefalu' (PA) , 90015, Italy
Pfizer Investigational Site
Chieti Scalo , 66013, Italy
Pfizer Investigational Site
Lecce , 73100, Italy
Pfizer Investigational Site
Livorno , 57123, Italy
Pfizer Investigational Site
Macerata , 62100, Italy
Pfizer Investigational Site
Napoli , 80131, Italy
Pfizer Investigational Site
Palermo , 90146, Italy
Pfizer Investigational Site
Pavia , 27100, Italy
Pfizer Investigational Site
Rimini , 47900, Italy
Pfizer Investigational Site
Roma , 00144, Italy
Pfizer Investigational Site
Goyang-si Gyeonggi-do, 410-7, Korea, Republic of
Pfizer Investigational Site
Seoul , 120-7, Korea, Republic of
Pfizer Investigational Site
Seoul , 138-7, Korea, Republic of
Pfizer Investigational Site
Nijmegen , 6525 , Netherlands
Pfizer Investigational Site
Utrecht , 3584 , Netherlands
Pfizer Investigational Site
Venlo , 5912 , Netherlands
Pfizer Investigational Site
Panama , , Panama
Pfizer Investigational Site
Gdansk , 80-95, Poland
Pfizer Investigational Site
Lubin , 59-30, Poland
Pfizer Investigational Site
Poznan , 61-87, Poland
Pfizer Investigational Site
Rybnik , 44-20, Poland
Pfizer Investigational Site
Warszawa , 02-78, Poland
Pfizer Investigational Site
Coimbra , 3000-, Portugal
Pfizer Investigational Site
Lisboa , 1099-, Portugal
Pfizer Investigational Site
Porto , 4200-, Portugal
Pfizer Investigational Site
Santa Maria da Feira , 4520-, Portugal
Pfizer Investigational Site
Cluj Napoca Cluj, 40001, Romania
Pfizer Investigational Site
Cluj Napoca Cluj, 40006, Romania
Pfizer Investigational Site
Craiova Dolj, 20064, Romania
Pfizer Investigational Site
Bucuresti Sector 2, 02232, Romania
Pfizer Investigational Site
Kuzmolovo, Vsevolozhsk district Leningrad region, 18866, Russian Federation
Pfizer Investigational Site
Moscow , 11547, Russian Federation
Pfizer Investigational Site
Moscow , 14342, Russian Federation
Pfizer Investigational Site
Saint Petersburg , 19506, Russian Federation
Pfizer Investigational Site
St. Petersburg , 19775, Russian Federation
Pfizer Investigational Site
Banska Bystrica , 975 1, Slovakia
Pfizer Investigational Site
Bratislava , 812 5, Slovakia
Pfizer Investigational Site
Bratislava , 833 1, Slovakia
Pfizer Investigational Site
Nitra , 949 0, Slovakia
Pfizer Investigational Site
Palma de Mallorca Baleares, 07010, Spain
Pfizer Investigational Site
Santiago de Compostela La Coruña, 15706, Spain
Pfizer Investigational Site
Dos Hermanas Sevilla, 41700, Spain
Pfizer Investigational Site
Barcelona , 08035, Spain
Pfizer Investigational Site
Madrid , 28034, Spain
Pfizer Investigational Site
Santa Cruz de Tenerife , 38320, Spain
Pfizer Investigational Site
Toledo , 45004, Spain
Pfizer Investigational Site
Valencia , 46009, Spain
Pfizer Investigational Site
Valencia , 46010, Spain
Pfizer Investigational Site
Valencia , 46014, Spain
Pfizer Investigational Site
Zaragoza , 50009, Spain
Pfizer Investigational Site
Helsingborg , 251 8, Sweden
Pfizer Investigational Site
Karlstad , 651 8, Sweden
Pfizer Investigational Site
Stockholm , 118 8, Sweden
Pfizer Investigational Site
Stockholm , 171 7, Sweden
Pfizer Investigational Site
Uppsala , 751 8, Sweden
Pfizer Investigational Site
Ankara , 06100, Turkey
Pfizer Investigational Site
Gaziantep , , Turkey
Pfizer Investigational Site
Istanbul , , Turkey
Pfizer Investigational Site
Dnipropetrovsk , 49102, Ukraine
Pfizer Investigational Site
Donetsk , 83092, Ukraine
Pfizer Investigational Site
Ivano-Frankivsk , 76018, Ukraine
Pfizer Investigational Site
Kyiv , 01103, Ukraine
Pfizer Investigational Site
Kyiv , 03115, Ukraine
Pfizer Investigational Site
Lviv , 79031, Ukraine
Pfizer Investigational Site
Cheltenham Gloucestershire, GL53 , United Kingdom
Pfizer Investigational Site
Maidstone Kent, ME16 , United Kingdom
Pfizer Investigational Site
Manchester M20 4bx, , United Kingdom
Pfizer Investigational Site
Wirral Merseyside, CH63 , United Kingdom
Pfizer Investigational Site
Shrewsbury Shropshire, SY3 8, United Kingdom
Pfizer Investigational Site
Telford Shropshire, TF1 6, United Kingdom
Pfizer Investigational Site
Guildford Surrey, GU2 5, United Kingdom
Pfizer Investigational Site
Worthing West Sussex, BN11 , United Kingdom
Pfizer Investigational Site
London , W6 8R, United Kingdom
Pfizer Investigational Site
Wolverhampton , WV10 , United Kingdom
Load More

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

594

Study ID:

NCT00393939

Recruitment Status:

Completed

Sponsor:


Pfizer

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider